Recent Articles

• 
  Medical / Regenerative Medicine

  "Stem Cell Therapy for Parkinson's Developed in Korea"

  A domestic research team has confirmed the safety and efficacy of an embryonic stem cell-derived Parkinson's disease treatment in clinical trials and published the results in an international journal. The clinical results showed improvement effects, such as patients who could not walk enjoying activ

  2025.10.14
• 
  Biotech

  KAIST Team Extracts PET Ingredients from Microbes

  ⓒNewsis KAIST research team has succeeded in obtaining benzene, toluene, ethylbenzene, and paraxylene (BTEX), which were previously only obtainable through petroleum refining, from bio-based materials. This achievement is evaluated as opening the possibility for reducing petroleum dependency and pro

  2025.10.13
• 
  Medical / Pharmaceutical

  Celltrion's Idencelt Gains Full U.S. Approval

  Celltrion Eydenzelt Prefilled Syringe (PFS) Product Image Celltrion announced on the 10th that it has received approval from the U.S. Food and Drug Administration (FDA) for its ophthalmic disease treatment 'Eydenzelt (development name CT-P42)'. Approval was obtained for two formulations: vial and pr

  2025.10.10
• 
  Medical / Digital Healthcare

  Open Healthcare Opens Major U.S. Diagnostic Center

  Key figures are cutting the ribbon at Open Healthcare's large-scale diagnostic testing center. Provided by Seegene Medical Foundation Healthcare specialist company Open Healthcare announced on the 10th that it has officially opened a large-scale diagnostic testing center in Gardena, California, USA.

  2025.10.10
• 
  Medical / Drug Development

  KAIST Scientist Exports New Drug for KRW 780 Billion

  Provided by KAIST KAIST has successfully achieved a global technology export valued at KRW 780 billion. On the 9th, KAIST announced that Sobagen, a faculty-founded startup by Professor Lee Jeong-ho of the Graduate School of Medical Science and Engineering, has transferred technology for a new drug c

  2025.10.10
• 
  Lotte Bio

  Shin Dong-bin: Lotte Bio's US Plant to Drive Growth

  Shin Dong-bin, Chairman of Lotte Group, visits the Lotte Biologics Syracuse Bio Campus in New York, USA, on the 5th (Korean time) to inspect the ADC production facility. Provided by Lotte Holdings Shin Dong-bin, Chairman of Lotte Group, visited the United States during the Chuseok holiday to inspect

  2025.10.10
• 
  Medical / Drug Development

  KAIST's KRW 780 Billion Epilepsy Drug Export to Italy

  Provided by KAIST KAIST has successfully achieved a global technology export deal worth KRW 780 billion. On the 9th, KAIST announced that Sobagen, a faculty startup founded by Professor Lee Jung-ho of the Graduate School of Medical Science and Engineering, has transferred technology for a new drug c

  2025.10.09
• 
  Medical / Drug Development

  Connext Aims for Global Pharma Status with CNT201

  ※ Hongneung Small and Medium-Sized Special Zone is a medical, bio, and healthcare cluster equipped with academia, research, and hospitals, discovering and supporting deep-tech startups in various fields. Introducing promising deep-tech startups that will thrive in the global market based on South Ko

  2025.10.02
• 
  MedTech

  Dentium Implant Training 'Zurich Course 2025' Concludes

  Photo provided by Dentium Global dental medical device specialist Dentium announced that the 'Zurich Course 2025', held in collaboration with the University of Zurich in Switzerland, concluded successfully. Dentium annually conducts advanced courses for implant clinicians in Zurich, Switzerland, thr

  2025.10.02
• 
  Medical / Biomanufacturing

  'PDA Biopharmaceutical Aseptic Conference 2025' in Incheon

  The 'PDA Bio Pharmaceutical Aseptic Processing Conference 2025' will be held at the Sheraton Grand Hotel in Incheon from November 4 to 5. This conference is organized to bring together experts from around the world to seek practical solutions and future strategies amidst the changing aseptic bio-man

  2025.10.01